Telehealth firm LifeMD said on Tuesday it would partner with Novo Nordisk to offer its diabetes drug Ozempic at $499 per month to eligible U.S. patients, including insured people whose plans do not cover GLP-1 therapies. Novo offers Ozempic for $499 a month to eligible…
Read Full Article (External Site)
